Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 December 2005

Lack of effect of hyperoxia on photodynamic therapy and lipid peroxidationin three different cancer cell lines.

John Akudugu

Med Sci Monit 2005; 11(12): LE22-22 :: ID: 438951

Abstract

Dear Editor,
In a recent study, Hjelde and co-workers investigated thepossible effects of oxygen tension on photodynamic toxicity in a panel of established cell lines [1].The authors established that high levels of hyperoxia did not impact on the extent of toxicity of photodynamictherapy, relative to that determined under normoxic conditions, and that this contrasted with other experimentaland clinical studies [2-4]. They attributed the lack of hyperoxic effect on phototoxicity to either theabsence of a hypoxic component in their cell cultures or the availability of sufficient oxygen to compensatefor oxygen depletion during the photochemical reaction. It is clear that the main reason for the significantoxygen effect observed in the other studies is that illumination and oxygenation occurred simultaneously[2-4]. To test any possible interaction between agents, it is mandatory for the agents to co-exist. Atleast, the damaging process of the inducing agent (the illumination) should be in progress during theapplication of the modifier (hyperoxia). Therefore, to harness an oxygen effect the hyperoxic conditionhas to be prevalent to 'fix' the damage during the induction of the extremely short-lived free radicals[5]. This crucial requirement could not be achieved by these investigators given the experimental constraintof illuminating prior to hyperoxic treatment. The time window between these steps was not commented on.This is a very important detail since phototoxicity depends concurrently on the oxygen tension and photosensitiserconcentration, and the photochemical reaction is expected to cease immediately after the illumination.It is worth noting that the lifetime of a typical triplet state photosensitiser which is the longestand main determinant of the reaction rate is of the order of 0.5 milliseconds [6]. It is therefore notsurprising that hyperoxic treatment following illumination did not affect phototoxicity in the currentinvestigation. Also, it is not evident from these data that high oxygen tension interfered with the damagerepair mechanisms of the cell lines used. The current conclusions may change significantly if the experimentaldesign is modified to enable illumination of the cell cultures under hyperoxia.
Sincerely,
John M. Akudugu,Radiation Biophysics, iThemba LABS, P. O. Box 722, Somerset West 7129, South Africa, e-mail: [email protected]
References:
1.Hjelde A, Gederaas OA, Krokan HE, Brubakk AO: Lack of effect of hyperoxia on photodynamictherapy and lipid peroxidation in three different cancer cell lines. Med Sci Monit, 2005; 11(10): BR351-BR356
2.Maier A, Anegg U, Fell B et al: Hyperbaric oxygen and photodynamic therapy in treatment of advancedcarcinoma of the cardia and the esophagus. Lasers Surg Med, 2000; 26: 308-15
3.Maier A, Tomaselli F,Anegg U et al: Combined photodynamic therapy and hyperbaric oxygenation in carcinoma of the esophagusand the esophago-gastric junction. Eur J Cardiothorac Surg, 2000; 18: 649-54 4.Chen Q, Huang Z, ChenH et al: Improvement of tumor response by manipulation of tumor oxygenation during photodynamic therapy.Photochem Photobiol, 2002; 76: 197-203
5.Hall EJ: Radiobiology for the radiologist. 3(rd) ed. Philadephia:JB Lippincott Company, 1988
6.Leeds University Centre for Photobiology and Photodynamic Therapy. Thescience of PDT. Available from: URL:http//www.bmb.leeds.ac.uk/pdt/science.htm Received: 2005.10.25.

Keywords: Aerobiosis, Lipid Peroxidation - drug effects, Neoplasms - drug therapy, Oxygen - therapeutic use, Photochemotherapy

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750